Cerus | CERS - Selling And Administration Expenses

Stock Price
2.02
Daily Change
0.01 0.25%
Monthly
11.94%
Yearly
55.00%
Q2 Forecast
1.84

Cerus reported $19.33M in Selling and Administration Expenses for its fiscal quarter ending in December of 2024.





Selling And Administration Expenses Change Date
Cerus USD 19.33M 1.55M Dec/2024
GRIFOLS EUR 275.3M 9.7M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.94M 20.44M Dec/2025
Terumo JPY 105.26B 7.38B Dec/2025
Utah Medical Products USD 2.61M 741K Dec/2025